Anti-ROCK2 monoclonal antibody
Pre-made anti-ROCK2 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research
Go to ROCK2/ROCK2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-T06093-Ab-1/ GM-Tg-hg-T06093-Ab-2 | Anti-Human ROCK2 monoclonal antibody | Human |
GM-Tg-rg-T06093-Ab-1/ GM-Tg-rg-T06093-Ab-2 | Anti-Rat ROCK2 monoclonal antibody | Rat |
GM-Tg-mg-T06093-Ab-1/ GM-Tg-mg-T06093-Ab-2 | Anti-Mouse ROCK2 monoclonal antibody | Mouse |
GM-Tg-cynog-T06093-Ab-1/ GM-Tg-cynog-T06093-Ab-2 | Anti-Cynomolgus/ Rhesus macaque ROCK2 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-T06093-Ab-1/ GM-Tg-felg-T06093-Ab-2 | Anti-Feline ROCK2 monoclonal antibody | Feline |
GM-Tg-cang-T06093-Ab-1/ GM-Tg-cang-T06093-Ab-2 | Anti-Canine ROCK2 monoclonal antibody | Canine |
GM-Tg-bovg-T06093-Ab-1/ GM-Tg-bovg-T06093-Ab-2 | Anti-Bovine ROCK2 monoclonal antibody | Bovine |
GM-Tg-equg-T06093-Ab-1/ GM-Tg-equg-T06093-Ab-2 | Anti-Equine ROCK2 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-T06093-Ab-1/ GM-Tg-hg-T06093-Ab-2; GM-Tg-rg-T06093-Ab-1/ GM-Tg-rg-T06093-Ab-2; GM-Tg-mg-T06093-Ab-1/ GM-Tg-mg-T06093-Ab-2; GM-Tg-cynog-T06093-Ab-1/ GM-Tg-cynog-T06093-Ab-2; GM-Tg-felg-T06093-Ab-1/ GM-Tg-felg-T06093-Ab-2; GM-Tg-cang-T06093-Ab-1/ GM-Tg-cang-T06093-Ab-2; GM-Tg-bovg-T06093-Ab-1/ GM-Tg-bovg-T06093-Ab-2; GM-Tg-equg-T06093-Ab-1/ GM-Tg-equg-T06093-Ab-2 |
Products Name | Anti-ROCK2 monoclonal antibody |
Format | mab |
Target Name | ROCK2 |
Protein Sub-location | Introcelluar Protein |
Category of antibody | Therapeutics Target antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected. |
Tag | Fc |
Products description | Pre-made anti-ROCK2 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | GM-Tg-g-T06093-Ag-1 | Recombinant multi-species ROCK2/ ROCK-II protein |
ORF Viral Vector | pGMAD000582 | human ROCK2 Adenovirus plasmid |
ORF Viral Vector | vGMAD000582 | human ROCK2 Adenovirus particle |
Target information
Target ID | GM-T06093 |
Target Name | ROCK2 |
Gene ID | 9475,19878,25537,708444,482970,101094501,282041,100072339 |
Gene Symbol and Synonyms | B230113H15Rik,mKIAA0619,Rho-kinase,ROCK-II,ROCK2,Rock2m,ROK,ROKalpha |
Uniprot Accession | O75116,Q62868,Q28021 |
Uniprot Entry Name | ROCK2_HUMAN,ROCK2_RAT,ROCK2_BOVIN |
Protein Sub-location | Introcelluar Protein |
Category | Therapeutics Target |
Disease | N/A |
Gene Ensembl | ENSG00000134318 |
Target Classification | Kinase |
The target: ROCK2, gene name: ROCK2, also named as ROCK-II. The protein encoded by this gene is a serine/threonine kinase that regulates cytokinesis, smooth muscle contraction, the formation of actin stress fibers and focal adhesions, and the activation of the c-fos serum response element. This protein, which is an isozyme of ROCK1 is a target for the small GTPase Rho. [provided by RefSeq, Jul 2008].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.